Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen–glucose depletion
Authors:
Open Access
- 18 August 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 161 (1) , 33-50
Abstract
BACKGROUND AND PURPOSESeveral clinical trials andin vivoanimal experiments have suggested that blockade of angiotensin receptor type 1 (AT1) improves ischaemic outcomes. However, the mechanism(s) underlying these effects has not been elucidated. Here, we have investigated the protective effects of pretreatment with AT1receptor antagonists, losartan or telmisartan, against ischaemic insult to neuronsin vitro.EXPERIMENTAL APPROACHPrimary rat neuron–astrocyte co‐cultures and astrocyte‐defined medium (ADM)‐cultured pure astrocyte cultures were prepared. Ischaemic injury was modelled by oxygen–glucose depletion (OGD) and lactate dehydrogenase release after OGD was measured with or without AT1receptor antagonists or agonists (L162313), AT2receptor antagonist (PD123319) or agonist (CGP‐42112A) pretreatment, for 48 h. Activity of glutamate transporter 1 (GLT‐1) was evaluated by [3H]‐glutamate uptake assays, after AT1receptor agonists or antagonists. Immunoblot and real‐time PCR were used for analysis of protein and mRNA levels of GLT‐1.KEY RESULTSAT1receptor agonists augmented OGD‐induced cellular damage, which was attenuated by AT1receptor antagonists. AT1receptor antagonists also suppressed OGD‐induced extracellular glutamate release, reactive oxygen species production and nitric oxide generation. GLT‐1 expression and glutamate uptake activity were significantly enhanced by AT1receptor antagonists and impaired by AT1receptor agonists. AT1receptor stimulation suppressed both ADM‐induced GLT‐1 protein expression and mRNA levels. AT1b receptor knock‐down with siRNA enhanced GLT‐1 expression. In postnatal (P1–P21) rat brains, protein levels of GLT‐1 and AT1receptors were inversely correlated.CONCLUSIONS AND IMPLICATIONSSuppression of AT1receptor stimulation induced GLT‐1 up‐regulation, which ameliorated effects of ischaemic injury.Keywords
This publication has 58 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- The Four Major N- and C-Terminal Splice Variants of the Excitatory Amino Acid Transporter GLT-1 Form Cell Surface Homomeric and Heteromeric AssembliesMolecular Pharmacology, 2009
- Presynaptic Regulation of Astroglial Excitatory Neurotransmitter Transporter GLT1Neuron, 2009
- Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1Neurochemistry International, 2008
- Focal transplantation–based astrocyte replacement is neuroprotective in a model of motor neuron diseaseNature Neuroscience, 2008
- Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic RetinaDiabetes, 2008
- Angiotensin receptor subtype mediated physiologies and behaviors: New discoveries and clinical targetsProgress in Neurobiology, 2008
- Transporters forL‐glutamate: An update on their molecular pharmacology and pathological involvementBritish Journal of Pharmacology, 2007
- Acute up‐regulation of glutamate uptake mediated by mGluR5a in reactive astrocytesJournal of Neurochemistry, 2005
- Non-peptide Angiotensin AgonistJournal of Biological Chemistry, 1995